Skip to content
10-Q

Quarterly Report

024 Pharma, Inc.

0001683168-16-000379

← back to feed
Filed
Oct 26, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Oct 20, 2016 336.35M sh
Stockholders Equity Q2 2016 · Jun 30, 2016 $31.2K
Stockholders Equity Q2 2016 · Dec 31, 2015 $512
Current Liabilities Q2 2016 · Jun 30, 2016 $28.23K
Current Assets Q2 2016 · Jun 30, 2016 $55.86K
Total Assets Q2 2016 · Jun 30, 2016 $59.43K
Rd Expense Q2 2016 · Jun 30, 2016 $0
Net Income Q2 2016 · Jun 30, 2016 $30.69K
Gross Profit Q2 2016 · Jun 30, 2016 $125.58K
Cost Of Revenue Q2 2016 · Jun 30, 2016 $218.04K
Revenue Q2 2016 · Jun 30, 2016 $343.61K